All the news Showing 10 of 717 articlesGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Hepatitis D Bulevirtide is a potential cure for hepatitis B and D Liz Highleyman / 16 April 2019 Bulevirtide, formerly known as Myrcludex B, led to suppression of hepatitis delta virus (HDV) and a functional cure of hepatitis B virus (HBV) in some people with both viruses when combined with pegylated ... NAFLD Obeticholic acid improves liver fibrosis in people with NASH Liz Highleyman / 12 April 2019 Obeticholic acid (Ocaliva) led to a significant improvement in liver fibrosis related to non-alcoholic steatohepatitis (NASH), offering a potential future option for an increasingly common liver disease with no good current therapies, researchers ... Pan-genotypic regimens Pangenotypic hepatitis C drug combinations curing almost all people who complete treatment, real-world studies show Keith Alcorn / 12 April 2019 Once-daily combination pills that can treat all genotypes of hepatitis C infection are curing almost everyone who completes a course of treatment, and drop-out rates during treatment are low, large 'real-world' cohort ... Finance, funding & health economics $51 billion price tag for eliminating hepatitis C by 2030 Keith Alcorn / 11 April 2019 To achieve hepatitis C elimination worldwide by 2030, governments, donors and the private sector will need to spend $51 billion but eliminating hepatitis C will lead to a $19 billion ... Screening policy 30 million screened for hepatitis C in four months in Egypt Keith Alcorn / 11 April 2019 Egypt screened almost 30 million people for hepatitis C in the first four months of a national screening programme that kicked off in October 2018, Egyptian researchers announced at The International Liver Congress ... Screening policy Same-day hepatitis C treatment initiation can be achieved at large scale, Egyptian pilot study shows Keith Alcorn / 11 April 2019 Screening for hepatitis C, confirmation of chronic infection by point-of-care viral load testing and treatment initiation can all be achieved on the same day in a community setting, Egyptian researchers reported at The ... Hepatitis B Global drive for hepatitis B cure launched at International Liver Congress Keith Alcorn / 10 April 2019 The Global Scientific Strategy to Cure Hepatitis B (The ICE-HBV Strategy) by the International Coalition to Eliminate HBV (ICE-HBV), a global group of researchers, patient representatives and health organisations, was released on the opening ... Screening and testing policy Is opt-out testing for HCV improving testing rates in UK prisons? Keith Alcorn / 04 April 2019 Testing rates for hepatitis C virus (HCV) in prisons in the United Kingdom remain far below the national minimum target of 50% and without radical change, prison testing rates will pose a ... Sexual transmission Epidemic of sexually transmitted hepatitis C in gay men now involves both HIV-positive and HIV-negative men Michael Carter / 29 March 2019 Incidence of acute hepatitis C virus (HCV) among men who have sex with men (MSM) who use pre-exposure prophylaxis (PrEP) in Lyon increased tenfold between 2016 and 2017, according to ... Hepatocellular carcinoma (HCC) Epigenetic changes persist after hepatitis C cure in liver cells, may predict liver cancer Keith Alcorn / 26 March 2019 Hepatitis C infection leaves permanent changes in the activity of genes in the liver even after the infection is cured and these changes are associated with an increased risk of liver cancer, ... ← First12345...72Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E NAFLD Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Noticeboard Email bulletins News feeds